The global IV infusion gravity bags market garnered a market value of US$ 723.8 Million in 2022 and is expected to accumulate a market value of US$ 1281.3 Million by registering a CAGR of 5.87% in the forecast period 2022 to 2032.
The growth of the IV infusion gravity bags market can be attributed to the increasing patient population along with the need for fluid transformation in the body. The market for IV infusion gravity bags registered a CAGR of 4.7% in the historical period 2016 to 2021.
Report Attribute | Details |
---|---|
Estimated Base Year Value (2021) | US$ 684.15 Million |
Expected Market Value (2022) | US$ 723.8 Million |
Anticipated Forecast Value (2032) | US$ 1281.3 Million |
Projected Growth Rate (2022 to 2032) | 5.87% CAGR |
IV infusion gravity bags are adopted for transferring medication straight into the intravenous of the patient. IV infusion gravity bags are based on gravitational pull which provides external pressure on the liquid (high height is directly proportional to higher pressure). IV infusion gravity bags are used for the fast transport of liquid medication throughout the patient’s body.
IV infusion gravity bags are mainly accepted for their use in fluid replacement therapies such as dehydration, and electrolyte imbalance, and also for blood transfusion. IV infusion gravity bags range from 50ml to 1000ml. In addition, IV infusion gravity bags are kept at height by hanging through the IV pole.
The IV infusion gravity bags mainly comprise of following parts a drip chamber, roller clamp, slide clamp, and an injection port. The working of IV infusion gravity bags is based on gravitational pressure that pushes liquid medication down through tubing/pipe into the patient’s veins.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The IV infusion gravity bags market shows healthy growth during the forecast period. The factors such as the increasing number of chronic disorders and an increasing number of surgeries on the global level are driving the growth of the IV infusion gravity bags market.
The IV infusion gravity bags carry infusion material for delivery into the patient’s vein. The flow of medication through IV infusion gravity bags is controlled by using a roller clamp device located on the IV pole. IV infusion gravity bags show a high rate of penetration owing to use in home care settings. The increasing penetration and ease in availability through the e-commerce website are boosting the growth of the IV infusion gravity bags market.
In addition, increasing the prevalence of malnutrition and blood transfusion processes in emerging economies are also gardening the market growth of IV infusion gravity bags.
The lack of sophisticated healthcare infrastructure and scarcity of skilled professionals in developing and under-developed regions are hindering the growth of the IV infusion gravity bags market. In addition, improper usage of IV infusion gravity bags is reducing the trust of the people in the bag. In creating geographical regions, the latest IV infusion gravity bags aren’t being used in healthcare facilities, thus, reducing the overall progress of the market.
North America is projected to hold the largest share of IV infusion gravity bags in the global market owing to increasing surgical procedures in this region. In addition, the presence of sophisticated healthcare facilities, and the rising prevalence of chronic and acute disorders are also gardening the growth of the IV infusion gravity bags market in North America
Due to the aforementioned reasons, North America is expected to possess a 33.9% market share for the IV infusion gravity bags market in 2022.
Technological advancement in the healthcare sector in Europe is positively influencing the demand for IV infusion gravity bags. The increasing geriatric population pool in the region is another key factor driving the growth of the market. In addition, favorable government initiatives and insurance policies are promoting the growth of IV infusion gravity bags.
Owing to the reasons mentioned above, Europe is expected to hold a 26% market share for the IV infusion gravity bags market in 2022.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market in Asia Pacific is anticipated to show the fastest CAGR over the forecast period owing to the presence of a large population base and an increasing number of hospitals and clinics. Moreover, the easy availability of IV infusion gravity bags is accelerating the market growth in the region. The increasing dominance of malnutrition in the Asia Pacific is increasing the demand for the IV infusion gravity bags market.
Asia Pacific is expected to procure a 22% market share for the IV infusion gravity bags market in 2022.
Key start-ups in the IV infusion gravity bags market are Shift Labs, 410 Medical, Navi Medical Technologies, Fosmo Med, Linear Health Services, and Lineus Medical
Some of the market participants in the global IV infusion gravity bags market are GVS, Sippex IV Bag, Kraton Corporation, ICU Medical, Inc., Baxter International Inc., Terumo BCT Ltd., The Metrix Company, Renolit, Technoflex, and Bioteque Corporation.
Report Attribute | Details |
---|---|
Market Value in 2022 | US$ 723.8 Million |
Market Value in 2032 | US$ 1281.3 Million |
Growth Rate | CAGR of 5.87% from 2022 to 2032 |
Base Year for Estimation | 2021 |
Historical Data | 2016 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
FMI projects the global IV infusion gravity bags market to expand at a 5.87% value CAGR by 2032
North America is expected to possess a 33.9% market share for the IV infusion gravity bags market in 2022.
GVS, Sippex IV Bag, Kraton Corporation, ICU Medical, Inc., Baxter International Inc., Terumo BCT Ltd., The Metrix Company, Renolit, Technoflex, and Bioteque Corporation are some prominent IV infusion gravity bags manufacturers
1. Executive Summary | IV Infusion Gravity Bags Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2016 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute Opportunity Analysis
5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Material Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Material Type, 2016 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Material Type, 2022 to 2032
5.3.1. Polypropylene (PP)
5.3.2. Polyvinyl Chloride (PVC)
5.3.3. Ethylene-Vinyl Acetate (EVA)
5.3.4. Low-Density Polyethylene (LDPE)
5.4. Y-o-Y Growth Trend Analysis By Material Type, 2016 to 2021
5.5. Absolute Opportunity Analysis By Material Type, 2022 to 2032
6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Layer Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Layer Type, 2016 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Layer Type, 2022 to 2032
6.3.1. Single Layer
6.3.2. Multiple Layer
6.4. Y-o-Y Growth Trend Analysis By Layer Type, 2016 to 2021
6.5. Absolute Opportunity Analysis By Layer Type, 2022 to 2032
7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2016 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Ambulatory Surgical Centers
7.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021
7.5. Absolute Opportunity Analysis By End User, 2022 to 2032
8. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2016 to 2021
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. United States of America
9.2.1.2. Canada
9.2.2. By Material Type
9.2.3. By Layer Type
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Material Type
9.3.3. By Layer Type
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Material Type
10.2.3. By Layer Type
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Material Type
10.3.3. By Layer Type
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Material Type
11.2.3. By Layer Type
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Material Type
11.3.3. By Layer Type
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Malaysia
12.2.1.6. Singapore
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia-Pacific (APAC)
12.2.2. By Material Type
12.2.3. By Layer Type
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Material Type
12.3.3. By Layer Type
12.3.4. By End User
12.4. Key Takeaways
13. MEA Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of Middle East and Africa (MEA)
13.2.2. By Material Type
13.2.3. By Layer Type
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Material Type
13.3.3. By Layer Type
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. United States of America
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Material Type
14.1.2.2. By Layer Type
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Material Type
14.2.2.2. By Layer Type
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Material Type
14.3.2.2. By Layer Type
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Material Type
14.4.2.2. By Layer Type
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Material Type
14.5.2.2. By Layer Type
14.5.2.3. By End User
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Material Type
14.6.2.2. By Layer Type
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Material Type
14.7.2.2. By Layer Type
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Material Type
14.8.2.2. By Layer Type
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Material Type
14.9.2.2. By Layer Type
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Material Type
14.10.2.2. By Layer Type
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Material Type
14.11.2.2. By Layer Type
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Material Type
14.12.2.2. By Layer Type
14.12.2.3. By End User
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Material Type
14.13.2.2. By Layer Type
14.13.2.3. By End User
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Material Type
14.14.2.2. By Layer Type
14.14.2.3. By End User
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Material Type
14.15.2.2. By Layer Type
14.15.2.3. By End User
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Material Type
14.16.2.2. By Layer Type
14.16.2.3. By End User
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Material Type
14.17.2.2. By Layer Type
14.17.2.3. By End User
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Material Type
14.18.2.2. By Layer Type
14.18.2.3. By End User
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Material Type
14.19.2.2. By Layer Type
14.19.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Material Type
15.3.3. By Layer Type
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Haemotronic Advanced Medical Technologies
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Sippex IV Bag
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Kraton Corporation
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. ICU Medical, Inc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Baxter International Inc.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Terumo BCT Ltd.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. The Metrix Company
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Renolit
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Technoflex
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Bioteque Corporation
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports